As part of ISOPP’s ongoing commitment to our members, we are seeking input to inform our strategic priorities, website revamp project, communication practices and advocacy initiatives.
During ISOPP’s 2019 Symposium, African participants highlighted several challenges to the introduction of biosimilars into their local practice during the Biosimilars Workshop.
The work of the ISOPP Advocacy Task Force is expected to ramp up during the remainder of 2021 and potentially on an ongoing basis. John Wiernikowski has been Chair of the Task Force since its inception and with the increasing activity, now is a good time to bring on a Co-Chair and initiate a succession planning process.
